Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Accuray Incorporated (ARAY)

2.02   0.02 (1%) 06-29 18:53
Open: 2 Pre. Close: 2
High: 2.075 Low: 1.98
Volume: 717,064 Market Cap: 187(M)
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.08 - 2.09 2.09 - 2.1
Low: 1.96 - 1.97 1.97 - 1.98
Close: 2 - 2.02 2.02 - 2.04

Technical analysis

as of: 2022-06-29 4:51:29 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.72     One year: 3.17
Support: Support1: 1.94    Support2: 1.7
Resistance: Resistance1: 2.32    Resistance2: 2.72
Pivot: 1.97
Moving Average: MA(5): 2.06     MA(20): 2.02
MA(100): 2.85     MA(250): 3.75
MACD: MACD(12,26): -0.1     Signal(9): -0.2
Stochastic oscillator: %K(14,3): 54.4     %D(3): 58.3
RSI: RSI(14): 46.6
52-week: High: 5.92  Low: 1.7
Average Vol(K): 3-Month: 1,275 (K)  10-Days: 2,750 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ARAY ] has closed below upper band by 42.6%. Bollinger Bands are 8.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 26 Jun 2022
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules - GuruFocus.com

Sun, 26 Jun 2022
Foundry Partners LLC Decreases Stock Holdings in Accuray Incorporated (NASDAQ:ARAY) - Defense World

Wed, 15 Jun 2022
2022-06-15 | NDAQ:ARAY | Press Release | Accuray Incorporated - Stockhouse

Tue, 14 Jun 2022
'Called to serve': Rabbi Shira Joseph retires after 19 years serving Hingham congregation - The Patriot Ledger

Mon, 13 Jun 2022
Here's Why You Should Hold on to Accuray (ARAY) Stock For Now - Nasdaq

Thu, 02 Jun 2022
Walking Dun na Cuaiche and the Aray, Inveraray - Argyllshire Advertiser

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 91 (M)
Shares Float 89 (M)
% Held by Insiders 4.4 (%)
% Held by Institutions 79.3 (%)
Shares Short 5,740 (K)
Shares Short P.Month 5,820 (K)

Stock Financials

EPS -0.09
EPS Est Next Qtl -0.03
EPS Est This Year -0.24
EPS Est Next Year -0.11
Book Value (p.s.) 0.5
Profit Margin (%) -3.1
Operating Margin (%) 2.3
Return on Assets (ttm) 1.3
Return on Equity (ttm) -20
Qtrly Rev. Growth -6.2
Gross Profit (p.s.) 1.75
Sales Per Share 4.73
EBITDA (p.s.) 0.17
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -24.05
PEG Ratio 0.1
Price to Book value 4.03
Price to Sales 0.42
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.